oxacillin has been researched along with Diabetes Mellitus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chang, Q; Chen, T; Mu, Q; Qian, C; Wu, R; Ye, J; Yu, J | 1 |
Chandrakanth, RK; Patil, SA; Sunagar, R | 1 |
Bartkovjak, M; Bauer, F; Benca, J; Bielova, M; Bukovinova, P; Findova, L; Holeckova, K; Huttova, M; Hvizdak, F; Karvaj, M; Kovac, M; Lesnakova, A; Luzica, R; Ondrusova, A; Sabo, I; Seckova, S; Shahum, A; Sladeckova, V; Svabova, V; Taziarova, M; Wiczmandyova, O | 1 |
Biró, L; Iván, E | 1 |
4 other study(ies) available for oxacillin and Diabetes Mellitus
Article | Year |
---|---|
Infection Characteristics and Drug Susceptibility of Multidrug-Resistant Bacteria in Patients with Diabetic Foot Ulcers.
Topics: Anti-Bacterial Agents; Coagulase; Diabetes Mellitus; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus | 2023 |
Bacteriophage therapy for Staphylococcus aureus bacteremia in streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Biological Therapy; Diabetes Complications; Diabetes Mellitus; Female; Humans; Mice; Mice, Inbred BALB C; Oxacillin; Staphylococcal Infections; Staphylococcus Phages; Streptozocin; Survival Analysis; Time Factors; Treatment Outcome | 2010 |
Neuroinfections due to Staphylococcus aureus: an emerging pathogen also in community acquired meningitis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Diabetes Complications; Diabetes Mellitus; Humans; Meningitis, Bacterial; Outcome Assessment, Health Care; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Study of bactericidal and bacteriostatic antibiotics in experimentally diabetic and senescent mice, in cases of lethal staphylococcal infection.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Erythromycin; Immunosuppression Therapy; Male; Mice; Neomycin; Oxacillin; Staphylococcal Infections | 1971 |